炎症四项对溃疡性结肠炎严重程度的预测价值

李媛, 卢灿省, 鲍炳州. 炎症四项对溃疡性结肠炎严重程度的预测价值[J]. 中国中西医结合消化杂志, 2024, 32(8): 707-710. doi: 10.3969/j.issn.1671-038X.2024.08.13
引用本文: 李媛, 卢灿省, 鲍炳州. 炎症四项对溃疡性结肠炎严重程度的预测价值[J]. 中国中西医结合消化杂志, 2024, 32(8): 707-710. doi: 10.3969/j.issn.1671-038X.2024.08.13
LI Yuan, LU Canxing, BAO Bingzhou. Predictive value of four items of inflammation for the severity of ulcerative colitis[J]. Chin J Integr Tradit West Med Dig, 2024, 32(8): 707-710. doi: 10.3969/j.issn.1671-038X.2024.08.13
Citation: LI Yuan, LU Canxing, BAO Bingzhou. Predictive value of four items of inflammation for the severity of ulcerative colitis[J]. Chin J Integr Tradit West Med Dig, 2024, 32(8): 707-710. doi: 10.3969/j.issn.1671-038X.2024.08.13

炎症四项对溃疡性结肠炎严重程度的预测价值

详细信息

Predictive value of four items of inflammation for the severity of ulcerative colitis

More Information
  • 目的 探讨炎症四项[C反应蛋白(C-reaction protein,CRP)、IL-6、血清淀粉样蛋白A(serum amyloid A,SAA)、降钙素原(procalcitonin,PCT)]在预测溃疡性结肠炎(ulcerative colitis,UC)严重程度方面的应用价值。方法 选取2020年12月—2023年12月在安徽中医药大学第一附属医院肛肠科住院治疗的UC患者为研究对象,将80例轻度患者设为对照组,155例中重度患者设为观察组。收集患者的临床资料及炎症四项数据。采用多因素logistic回归分析研究UC严重程度的影响因素,采用ROC曲线分析炎症四项对UC严重程度的预测效果。结果 观察组WBC、RBC、纤维蛋白原、CRP、IL-6、PCT、SAA均高于对照组(均P < 0.001),血清白蛋白低于对照组(P < 0.001)。多因素logistic回归分析结果显示,CRP、IL-6、PCT、SAA是UC严重程度的独立影响因素(P < 0.001)。ROC曲线分析结果显示,CRP、IL-6、PCT、SAA及四者联合预测中重度UC的AUC分别为0.791、0.728、0.781、0.751、0.895;四者联合预测中重度UC的AUC均大于CRP、IL-6、PCT、SAA单独预测的AUC(均P < 0.001)。结论 CRP、IL-6、PCT、SAA是UC严重程度的独立影响因素,且四者联合预测UC严重程度具备较高临床价值。
  • 加载中
  • 图 1  CRP、IL-6、PCT、SAA及四项联合预测中重度UC的ROC曲线

    表 1  两组患者的临床资料及血清相关指标比较 X±S,例(%),M(P25P75)

    指标 观察组(n=155) 对照组(n=80) t2/Z P
    年龄/岁 45.55±14.98 44.46±15.35 -0.456 0.649
    性别 0.108 0.743
      男 81(52.26) 40(50.00)
      女 74(47.74) 40(50.00)
    BMI 21.96±2.54 22.53±5.05 -0.295 0.768
    病程/d 22.85±4.95 23.07±5.43 0.275 0.783
    病变范围 5.348 0.253
      直肠 23(14.84) 14(17.50)
      直肠乙状结肠 32(20.64) 25(31.25)
      左半结肠 38(24.52) 17(21.25)
      全结肠 42(27.10) 19(23.75)
      区域性结肠 20(12.90) 5(6.25)
    WBC/(×109/L) 8.07(6.51,9.63) 5.28(4.54,6.27) -8.957 < 0.001
    RBC/(×109/L) 6.84(4.93,9.07) 4.43(3.82,4.68) -8.955 < 0.001
    ESR/(mm/h) 14.09(9.12,20.03) 10.15(6.97,22.78) -1.158 0.114
    Fib/(g/L) 3.46(2.12,4.75) 2.76(1.85,3.63) -3.365 < 0.001
    ALB/(g/L) 33.99(30.98,37.68) 38.13(36.30,40.34) -5.438 < 0.001
    CRP/(mg/L) 14.62(6.68,24.35) 5.47(3.56,8.26) -7.300 < 0.001
    IL-6/(ng/L) 13.76(9.90,20.29) 8.58(4.66,12.20) -5.720 < 0.001
    PCT/(μg/L) 1.43(1.15,1.68) 1.08(0.78,1.30) -7.052 < 0.001
    SAA/(mg/L) 36.58(33.11,42.46) 30.11(25.85,36.21) -6.304 < 0.001
    下载: 导出CSV

    表 2  中重度UC危险因素的logistic回归分析

    变量 β SE Wald χ2 P OR 95%CI
    CRP 0.178 0.031 32.572 < 0.001 1.195 1.124~1.270
    IL-6 2.007 0.384 27.276 < 0.001 7.439 3.503~15.797
    PCT 0.221 0.036 38.574 < 0.001 1.247 1.163~1.337
    SAA 0.148 0.025 34.700 < 0.001 1.159 1.104~1.218
    下载: 导出CSV

    表 3  CRP、IL-6、PCT、SAA及四项联合对中重度UC的预测价值

    指标 AUC 灵敏度 特异度 最佳截断值 95%CI P
    CRP 0.791 0.639 0.838 10.180 mg/L 0.791~0.847 < 0.001
    IL-6 0.728 0.645 0.725 11.600 ng/L 0.728~0.797 < 0.001
    PCT 0.781 0.768 0.637 1.135 μg/L 0.781~0.840 < 0.001
    SAA 0.751 0.819 0.613 31.625 mg/L 0.751~0.818 < 0.001
    四项联合 0.895 0.903 0.712 0.895~0.934 < 0.001
    下载: 导出CSV
  • [1]

    沈洪, 唐志鹏, 唐旭东, 等. 消化系统常见病溃疡性结肠炎中医诊疗指南(基层医生版)[J]. 中华中医药杂志, 2019, 34(9): 4155-4160. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201909068.htm

    [2]

    Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review[J]. JAMA, 2023, 330(10): 951-965. doi: 10.1001/jama.2023.15389

    [3]

    Lillian D, Christina H. Epidemiology and Pathogenesis of Ulcerative Colitis[J]. Gastroenterol Clin N, 2020, 49(4): 643-654. doi: 10.1016/j.gtc.2020.07.005

    [4]

    Arik S, Mona S, Regina M, et al. Serum albumin levels and inflammation[J]. Int J Biol Macromol, 2021, 184(1): 857-862.

    [5]

    Ishida N, Higuchi T, Miyazu T, et al. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis[J]. Sci Rep, 2021, 11(1): 12431. doi: 10.1038/s41598-021-90558-z

    [6]

    吴东升, 曹晖, 张彧, 等. 基于IL-6/STAT3通路探讨芍药汤对溃疡性结肠炎Th17/Treg平衡的调节机制[J]. 中国实验方剂学杂志, 2023, 29(9): 46-52. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202309006.htm

    [7]

    袁雪梅, 韩小琴, 韦梅, 等. 早期肝素结合蛋白联合降钙素原对重症肺炎患者的预后评估价值[J]. 临床急诊杂志, 2022, 23(8): 553-556. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202208002.htm

    [8]

    Masaki W, Ryohei H, Yoshitaka U, et al. Promoting mechanism of serum amyloid a family expression in mouse intestinal epithelial cells[J]. PloS One, 2022, 17(3): e0264836. doi: 10.1371/journal.pone.0264836

    [9]

    Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis[J]. Inflamm Bowel Dis, 2008, 14(12): 1660-1666. doi: 10.1002/ibd.20520

    [10]

    王建成, 齐洪军, 郭洁洁. 溃疡性结肠炎的中医药治疗研究进展[J]. 实用中医内科杂志, 2024, 38(2): 106-109. https://www.cnki.com.cn/Article/CJFDTOTAL-SYZY202402032.htm

    [11]

    Mariame M, Asma HL, Azzedine B, et al. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein[J]. Ann Biol Clin (Paris), 2017, 75(2): 225-229.

    [12]

    Helena E, Birgitta G, Leena ME, et al. C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205[J]. Front Immunol, 2021, 11: 622326. doi: 10.3389/fimmu.2020.622326

    [13]

    陈佳园, 陈怡, 陈成帷, 等. 溃疡性结肠炎患者C反应蛋白/白蛋白比值与疾病活动性的相关性研究[J]. 浙江中西医结合杂志, 2022, 32(11): 1018-1021. doi: 10.3969/j.issn.1005-4561.2022.11.009

    [14]

    Zhang J, Cao L, Sun Y, et al. The Regulatory Effects of Licochalcone A on the Intestinal Epithelium and Gut Microbiota in Murine Colitis[J]. Molecules, 2021, 26(14): 4149. doi: 10.3390/molecules26144149

    [15]

    Veselinova TV, Lyuba M, Noyko S, et al. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer[J]. World J Gastroenterol, 2020, 26(16): 1912-1925. doi: 10.3748/wjg.v26.i16.1912

    [16]

    崔畅婉, 孙峥嵘. 溃疡性结肠炎发病机制研究进展[J]. 现代免疫学, 2019, 39(1): 77-81. https://www.cnki.com.cn/Article/CJFDTOTAL-SHMY201901015.htm

    [17]

    马亚南, 刘雯, 柴新梅, 等. 粪便钙卫蛋白联合CD64指数及超敏C反应蛋白在儿童细菌性肠炎诊断中的临床价值[J]. 中国中西医结合消化杂志, 2023, 31(9): 691-695. doi: 10.3969/j.issn.1671-038X.2023.09.07

    [18]

    Cleland DA, Eranki AP. Procalcitonin[M]. Treasure Island(FL): StatPearls Publishing, 2024: 1-1.

    [19]

    Samsudin I, Vasikaran SD. Clinical Utility and Measurement of Procalcitonin[J]. Clin Biochem Rev, 2017, 38(2): 59-68.

    [20]

    朱晓夏, 陈言语, 周晓俊, 等. 细菌感染与血清炎症指标间关系及其诊断价值[J]. 热带医学杂志, 2022, 22(9): 1243-1247. https://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ202209015.htm

    [21]

    Hou Y, Zhao W, Yang Z. Serum amyloid A(SAA)and Interleukin-6(IL-6) as the potential biomarkers for gastric cancer[J]. Medicine(Baltimore), 2022, 101(43): e31514.

    [22]

    Sack GH Jr. Serum Amyloid A(SAA)Proteins[J]. Subcell Biochem, 2020, 94: 421-436.

    [23]

    Chen R, Chen Q, Zheng J, et al. Serum amyloid protein A in inflammatory bowel disease: from bench to bedside[J]. Cell Death Discov, 2023, 9(1): 154.

  • 加载中
计量
  • 文章访问数:  236
  • 施引文献:  0
出版历程
收稿日期:  2023-11-19
刊出日期:  2024-08-15

返回顶部

目录